{"filings":[{"id":808436,"accession_number":"0001213900-26-064285","cik":2015502,"company_name":"Launch One Acquisition Corp.","ticker":"LPAA","form_type":"8-K","filed_at":"2026-06-02T21:15:16+00:00","items":["5.02"],"status":"ready","headline":"Launch One Acquisition Corp appoints Daniel Clifford Rogers to board, replacing Risa Stack as audit committee chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Risa Stack resigned from the Board and as audit committee chair, effective June 2, 2026; no disagreement cited.","Daniel Clifford Rogers appointed as director and audit committee chair, filling the vacancy left by Stack.","Rogers, 56, brings CFO experience from Newcourt Acquisition, Papaya Growth, Helpshift, and fintech advisory.","Rogers entered standard indemnity agreement and joined existing letter agreement and registration rights agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":310356263.03017646,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111808,"accession_number":"0001213900-26-034702","cik":2015502,"company_name":"Launch One Acquisition Corp.","ticker":"LPAA","form_type":"8-K","filed_at":"2026-03-26T23:59:59+00:00","items":["2.03","8.01","9.01"],"status":"ready","headline":"Launch One Acquisition secures up to $1M working capital note from sponsor; 51% founder shares pledged as collateral","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Note allows up to $1,000,000 in loans; original issue discount of 20% yields $1,250,000 principal amount.","Initial $500,000 loan funded at issuance; two additional $250,000 tranches at sponsor's election.","Interest rate of 8% (26% default); maturity upon business combination or liquidation.","Sponsor pledged 2,932,500 Class B ordinary shares (~51% of founder shares) under separate Credit Agreement.","Proceeds to cover past and ongoing operational expenses due to limited year-end cash."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":310356263.03017646,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111807,"accession_number":"0001213900-26-011726","cik":2015502,"company_name":"Launch One Acquisition Corp.","ticker":"LPAA","form_type":"8-K","filed_at":"2026-02-04T23:59:59+00:00","items":["1.02","9.01"],"status":"ready","headline":"Launch One Acquisition terminates business combination with Minovia Therapeutics","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Mutual termination effective Jan 30, 2026; BCA originally signed June 25, 2025 and amended four times.","Each party released the others from all liabilities and damages related to the transaction documents.","Ancillary agreements (voting, lock-up, sponsor letter) automatically terminated concurrently.","SPAC and its sponsor intend to seek alternative ways to consummate an initial business combination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":310356263.03017646,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":145221,"accession_number":"0001213900-25-060421","cik":2015502,"company_name":"Launch One Acquisition Corp.","ticker":"LPAA","form_type":"8-K","filed_at":"2025-07-01T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Launch One SPAC to acquire Minovia Therapeutics in $180M de-SPAC merger","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration $180M in Pubco shares, plus $57.5M earnout tied to stock price ≥$11.50 or phase 3 trial start.","Minimum cash condition at close: at least $23M, with bridge financing of $5M within 30 days and additional $18M financing.","Sponsor to subject 22.5% of founder shares to earnout/forfeiture; 1-year lock-up for directors and ≥3% holders.","Closing expected by Dec 24, 2025; requires SPAC and Minovia shareholder approvals.","Post-closing board: 8 directors (5 from Minovia, 1 from sponsor, 2 from Alex Greystoke/Jon Bakhshi)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":310356263.03017646,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163647,"accession_number":"0001213900-25-057488","cik":2015502,"company_name":"Launch One Acquisition Corp.","ticker":"LPAA","form_type":"8-K","filed_at":"2025-06-25T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Launch One Acquisition Corp. to combine with Minovia Therapeutics at $180M valuation, targeting Q4 2025 close","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Minovia pre-money valuation of $180M; equity holders eligible for up to $57.5M earnout based on milestones.","Launch One trust holds ~$239.7M cash; at least $18M in PIPE investments and $5M bridge financing expected.","Lead product MNV-201 has FDA Fast Track and Rare Pediatric Disease designations; pivotal trial in preparation.","Transaction unanimously approved by both boards; expected to close Q4 2025 subject to shareholder approvals.","Combined company to be named Mito US One Ltd. and list on Nasdaq under new ticker."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":310356263.03017646,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":214438,"accession_number":"0001213900-24-073891","cik":2015502,"company_name":"Launch One Acquisition Corp.","ticker":"LPAA","form_type":"8-K","filed_at":"2024-08-29T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Launch One Acquisition announces separate trading of shares and warrants from September 3, 2024","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Holders of units (LPAAU) may elect to separate into Class A shares (LPAA) and warrants (LPAAW) starting September 3, 2024.","No fractional warrants will be issued; only whole warrants will trade upon separation.","Unseparated units will continue trading on Nasdaq under LPAAU.","Transfer agent Continental Stock Transfer & Trust will process separations via brokers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":310356263.03017646,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":214437,"accession_number":"0001213900-24-063079","cik":2015502,"company_name":"Launch One Acquisition Corp.","ticker":"LPAA","form_type":"8-K","filed_at":"2024-07-19T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Launch One Acquisition Corp. completes $230M IPO and $6M private placement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 23M units at $10.00 each (including full over-allotment of 3M units) for gross proceeds of $230M.","Placed $230M ($10.00/unit) in trust account; shares subject to possible redemption at $10.00 per share.","Issued 6M private placement warrants at $1.00 each to sponsor and underwriter representative, raising $6M.","Transaction costs total $15.6M including $4M cash underwriting fee and $10.95M deferred underwriting fee.","Shareholders' deficit of $9.65M as of July 15, 2024; company has 24 months to complete business combination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":310356263.03017646,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":214436,"accession_number":"0001213900-24-061349","cik":2015502,"company_name":"Launch One Acquisition Corp.","ticker":"LPAA","form_type":"8-K","filed_at":"2024-07-15T23:59:59+00:00","items":["1.01","2.03","3.02","5.03","8.01","9.01"],"status":"ready","headline":"Launch One Acquisition Corp. closes $230M IPO, trust funded","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Closed IPO of 23,000,000 units at $10.00/unit, gross proceeds $230M; includes full over-allotment exercise.","Issued 6M private placement warrants ($1 each) to sponsor (4M) and Cantor (2M), raising $6M; exercisable at $11.50.","Placed $230M of total proceeds into trust; funds released only upon business combination or liquidation within 24 months.","Amended sponsor promissory note: loan limit increased from $300K to $340K, no interest, repayable at IPO closing.","SPAC focus is healthcare/life sciences globally; led by CEO Chris Ehrlich, Chairman Ryan Gilbert, CFO Jurgen van de Vyver."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":310356263.03017646,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}